Nektar Therapeutics (NKTR)

Nektar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	127	172	108	425	2,493	3,050
Market Cap Growth	59.16%	59.16%	-74.63%	-82.96%	-18.24%	-19.68%
Enterprise Value	52	129	-20	179	1,866	2,117
Last Close Price	0.68	0.93	0.56	2.26	13.51	17.00
PS Ratio	1.42	1.74	1.20	4.61	24.47	19.94
PB Ratio	2.08	2.82	0.82	1.16	3.67	2.83
P/TBV Ratio	2.82	2.82	0.82	1.46	4.14	3.05
EV/Sales Ratio	0.53	1.31	-	1.94	18.31	13.84
Debt / Equity Ratio	3.20	3.20	1.76	0.78	0.50	0.33
Asset Turnover	0.28	0.28	0.16	0.10	0.08	0.09
Inventory Turnover	-	-	1.91	1.24	1.60	1.39
Quick Ratio	4.18	4.18	5.97	7.53	8.90	9.55
Current Ratio	4.26	4.26	6.45	8.01	9.34	9.83
Return on Equity (ROE)	-124.10%	-124.10%	-110.95%	-70.39%	-59.64%	-35.80%
Return on Assets (ROA)	-23.14%	-23.14%	-15.25%	-16.43%	-21.00%	-13.51%
Return on Capital (ROIC)	-26.34%	-26.34%	-16.66%	-17.96%	-22.80%	-14.33%
Earnings Yield	-94.00%	-69.35%	-256.12%	-86.68%	-21.01%	-14.57%
FCF Yield	-140.01%	-103.28%	-179.50%	-72.91%	-17.15%	-10.51%
Buyback Yield / Dilution	-8.24%	-8.24%	-1.53%	-2.10%	-2.64%	-2.05%

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q